Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Martin Neil Reaume"'
Autor:
David J. Stewart, Donna E. Maziak, Sara M. Moore, Stephanie Y. Brule, Marcio Gomes, Harman Sekhon, Carole Dennie, Bryan Lo, Michael Fung‐Kee‐Fung, John‐Peter Bradford, Martin Neil Reaume
Publikováno v:
Cancer Medicine, Vol 10, Iss 24, Pp 9040-9046 (2021)
Abstract Background Systemic therapy prolongs overall survival (OS) in advanced non‐small cell lung cancer (NSCLC), but diagnostic tests, staging and molecular profiling take time, and this can delay therapy initiation. OS approximates first‐orde
Externí odkaz:
https://doaj.org/article/d7f5dfe320e94a5882ae4bb5202cae9f
Autor:
Christopher J Sweeney, Andrew J Martin, Martin R Stockler, Stephen Begbie, Leanna Cheung, Kim N Chi, Simon Chowdhury, Mark Frydenberg, Lisa G Horvath, Anthony M Joshua, Nicola J Lawrence, Gavin Marx, John McCaffrey, Ray McDermott, Margaret McJannett, Scott A North, Francis Parnis, Wendy Parulekar, David W Pook, Martin Neil Reaume, Shahneen K Sandhu, Alvin Tan, Thean Hsiang Tan, Alastair Thomson, Francisco Vera-Badillo, Scott G Williams, Diana Winter, Sonia Yip, Alison Y Zhang, Robert R Zielinski, Ian D Davis, Ehtesham Abdi, Suzanne Allan, Patricia Bastick, Robert Blum, Karen Briscoe, Daniel Brungs, Sean Bydder, Bala Renuka Chittajallu, Michelle Cronk, Katharine Cuff, Anthony Dowling, Matthew George, Lisa Horvath, Elizabeth Hovey, Anthony Joshua, Narayan Karanth, Ganessan Kichenadasse, Laurence Krieger, Maitham Mathlum, Louise Nott, Zulfiquer Otty, David Pook, Shahneen Sandhu, Sanjeev Sewak, Amanda Stevanovic, Martin Stockler, Aneta Suder, Hsiang Tan, Javier Torres, Simon Troon, Craig Underhill, Andrew Weickhardt, Robert Zielinski, Tahir Abbas, Ghadeer Anan, Chris Booth, Holly Campbell, Kim Chi, Joseph Chin, Edmond Chouinard, Bryan Donnelly, Darrel Drachenberg, Amir Faghih, Antonio Finelli, Sebastien Hotte, Krista Noonan, Scott North, Mohammad Rassouli, Neil Reaume, Ricardo Rendon, Fred Saad, Evgeny Sadikov, Eric Vigneault, Pawel Zalewski, Patrick Morris, Miriam O'Connor, Paul Donnellan, Dearbhaile O'Donnell, Jim Edwards, Peter Fong, Simon Crabb, Omar Khan, Vincent Khoo, Graham Macdonald, Heather Payne, Angus Robinson, Jonathon Shamash, John Staffurth, Carys Thomas
Publikováno v:
The Lancet Oncology. 24:323-334
Autor:
Bryan Lo, Stephanie Brule, John-Peter Bradford, Carole Dennie, David J. Stewart, Donna E. Maziak, Sara M. Moore, Marcio M. Gomes, Martin Neil Reaume, Michael Fung-Kee-Fung, Harman Sekhon
Publikováno v:
Cancer Medicine
Cancer Medicine, Vol 10, Iss 24, Pp 9040-9046 (2021)
Cancer Medicine, Vol 10, Iss 24, Pp 9040-9046 (2021)
Background Systemic therapy prolongs overall survival (OS) in advanced non‐small cell lung cancer (NSCLC), but diagnostic tests, staging and molecular profiling take time, and this can delay therapy initiation. OS approximates first‐order kinetic
Publikováno v:
Journal of evaluation in clinical practice. 28(3)
Randomized trials are considered the gold standard when assessing the efficacy of new therapeutic agents. In clinical situations where no standard of care therapy is approved, randomized trials usually compare experimental agents to either a placebo
Autor:
Daniel Heng, Denis Soulières, Sara Nazha, Lori Wood, Christian Kollmannsberger, Anil Kapoor, Éric Lévesque, Michael A.S. Jewett, Alice Dragomir, Martin Neil Reaume, Georg A. Bjarnason, Naveen S. Basappa, Simon Tanguay
Publikováno v:
Clinical Drug Investigation. 38:1155-1165
The development of new targeted therapies in kidney cancer has shaped disease management in the metastatic phase. Our study aims to conduct a cost-utility analysis of sunitinib versus pazopanib in first-line setting in Canada for metastatic renal cel
Autor:
Saliba I, Philippe D. Violette, Jean-Baptiste Lattouf, Darrel Drachenberg, Alan So, Major P, Simon Tanguay, Martin Neil Reaume, Jane Green, Raymond H. Kim, Silver S, Leicht R, Joan Basiuk, Michael A.S. Jewett, Melanie Care, Stephen E. Pautler
Publikováno v:
Canadian Urological Association journal = Journal de l'Association des urologues du Canada. 10(7-8)
Introduction: Optimal clinical assessment and subsequent followup of patients with or suspected of having a hereditary renal cell carcinoma syndrome (hRCC) is not standardized and practice varies widely. We propose protocols to optimize these process
Autor:
Natasha Wiebe, Scott Klarenbach, Braden J. Manns, Brenda R. Hemmelgarn, Helen Lee, Tony Reiman, Martin Neil Reaume, Anita Lloyd, Marcello Tonelli
Publikováno v:
Cancer. 116(13)
BACKGROUND: Erythropoiesis-stimulating agents (ESA) administered to cancer patients with anemia reduce the need for blood transfusions and improve quality-of-life (QOL). Concerns about toxicity have led to more restrictive recommendations for ESA use